Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...
AstraZeneca's IL-33-targeting antibody tozorakimab has made the grade in two phase 3 chronic obstructive pulmonary disease (COPD) trials, raising the prospects of a class that has recorded some ...
Airway epithelial cells are frontline sentinels that detect, restrict, and orchestrate immune responses to respiratory viruses. Beyond canonical interferon ...
The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...
Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...
So I made a vow, right there in the quiet. Nothing dramatic. Nothing that requires more energy than I have. Just this: Every ...
Coal-fired power generation remains a central component of Sri Lanka’s energy mix, with the Lakvijaya (Norochcholai) Power Plant contributing a substantial share of national electricity production.
The burden of RSV-associated hospitalization was high in older adults, with the greatest risk among the oldest age strata and those with CHF.
Going from a medium-dose inhaled corticosteroid to a biologic for asthma led to significant decreases in exacerbations, ...
Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.
BACKGROUND: Pulmonary rehabilitation has become a cornerstone in the management of patients with stable Chronic Obstructive Pulmonary Disease (COPD). Systematic reviews have shown large and important ...
MyChesCo on MSN
AstraZeneca drug cuts COPD exacerbations in phase III trials
WILMINGTON, DE — AstraZeneca (NYSE: AZN) said its experimental drug tozorakimab reduced moderate-to-severe exacerbations in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results